VOLITIONRX LTD — Director's Dealing 2018

Jan 25, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2018-01-23

Reporting Person: Micallef Jacob Vincent (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-23	Stock Option (Right to Buy)	$4	A	75000	Acquired	2024-01-23	Common Stock (75000)	Direct

Footnotes

F1: A total of 75,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.